A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Marine Fidelle(Inserm), Romain Daillère(Institut Gustave Roussy), Eugénie Pizzato(Inserm), Satoru Yonekura(Inserm), Corentin Richard(Centre Georges François Leclerc), Maxime Descartes Mbogning Fonkou(Inserm), Charles‐Antoine Dutertre(Inserm), Nadine Gervois(Centre National de la Recherche Scientifique), Lucas Blanchard(Laboratory of Molecular Genetics), Cécile Dalban(Centre Léon Bérard), Safae Terrisse(Assistance Publique – Hôpitaux de Paris), Carolina Alves Costa Silva(Institut Gustave Roussy), Nathalie Labarrière(Inserm), Florent Ginhoux(SingHealth), Maryam Tidjani Alou(Université Paris-Sud), Giacomo Vitali(Université Paris-Saclay), Kevin Mulder(Inserm), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Sebastian Kobold(German Cancer Research Center), Anna Reni(University of Verona), Cassandra Thélémaque(Inserm), Marion Leduc(Inserm), Silvia Zoppi(University of Parma), Conrad Rauber(Université Paris-Sud), Ai-Ling Tian(Inserm), Oliver Kepp(Inserm), Ronald Koschny(Heidelberg University), Imran Lahmar(Inserm), Pierre Ly(Inserm), Jean‐Philippe Girard(Université Toulouse III - Paul Sabatier), Angela Schippers(RWTH Aachen University), Jean‐Eudes Fahrner(Inserm), Gladys Ferrere(Institut Gustave Roussy), Benoît Quinquis(Université Paris-Saclay), Jianzhou Chen(Inserm), Emmanuelle Le Chatelier(Université Paris-Saclay), Aymeric Silvin(Inserm), Anne Jarry(Centre National de la Recherche Scientifique), Emmanuelle Godefroy(Centre National de la Recherche Scientifique), Roxanne Birebent(Inserm), Leonardo Lordello(Université Paris Cité), Sylvère Durand(Inserm), Anne-Laure Mallard de La Varende(Inserm), Isabelle Lebhar(Inserm), Liwei Zhao(Université Paris Cité), Norbert Wagner(Universitätsklinikum Aachen), María Paula Roberti(German Cancer Research Center), Jacques Bosq(Embody (France)), Nathalie Galleron(Université Paris-Saclay), Javier Suárez-Gosálvez(Center for Integrated Protein Science Munich)
Cited by 216
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
Origin and differentiation of microglia
|Frontiers in Cellular Neuroscience|2013|893
Interleukin‐33 (<scp>IL</scp>‐33): A nuclear cytokine from the <scp>IL</scp>‐1 family
|Immunological Reviews|2017|847